Skip to main content
Premium Trial:

Request an Annual Quote

Paracel Sells GeneMatcher2 to Three European Research Centers

NEW YORK, June 29 (GenomeWeb News) - Paracel said today that it has signed three new customers in Europe for its GeneMatcher2 sequence analysis system -- the Nestlé Research Center in Switzerland, the University of Wuerzburg in Germany, and the Institute of Molecular Pathology in Austria.


Paracel, a subsidiary of the Celera Genomics Group of Applera, said that the NestléResearchCenter added the GeneMatcher2 to an infrastructure that already included Paracel's BlastMachine2 system for accelerated Blast searching.


The University of Wuerzburg said it will use GeneMatcher2 to support its research in functional genome analysis and comparative genomics, while the Institute of Molecular Pathology will integrate the system into its in-house genome annotation platform.

The Scan

Purnell Choppin Dies

Purnell Choppin, a virologist who led the Howard Hughes Medical Institute, has died at 91, according to the Washington Post.

Effectiveness May Decline, Data From Israel Suggests

The New York Times reports that new Israeli data suggests a decline in Pfizer-BioNTech SARS-CoV-2 vaccine effectiveness against Delta variant infection, though protection against severe disease remains high.

To See Future Risk

Slate looks into the use of polygenic risk scores in embryo screening.

PLOS Papers on Methicillin-Resistant Staphylococcus, Bone Marrow Smear Sequencing, More

In PLOS this week: genomic analysis of methicillin-resistant Staphylococcus pseudintermedius, archived bone marrow sequencing, and more.